BlackRock
NUTX

BlackRock’s Nutex Health NUTX Stock Holding History

BlackRock’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.1M Buy
379,355
+97,802
+35% +$12M ﹤0.01% 2725
2025
Q4 		$46.3M Buy
281,553
+19,175
+7% +$2.54M ﹤0.01% 2565
2025
Q3 		$27.1M Buy
262,378
+14,431
+6% +$1.42M ﹤0.01% 2901
2025
Q2 		$30.9M Buy
247,947
+210,939
+570% +$27.2M ﹤0.01% 2765
2025
Q1 		$1.74M Buy
37,008
+6,267
+20% +$306K ﹤0.01% 4033
2024
Q4 		$974K Hold
30,741
– – ﹤0.01% 4229
2024
Q3 		$667K Buy
30,741
+1
+0% +$14 ﹤0.01% 4261
2024
Q2 		$183K Hold
30,740
– – ﹤0.01% 4567
2024
Q1 		$442K Hold
30,740
– – ﹤0.01% 4400
2023
Q4 		$830K Sell
30,740
-4,170
-12% -$130K ﹤0.01% 4307
2023
Q3 		$1.06M Buy
34,910
+30,671
+724% +$1.48M ﹤0.01% 4223
2023
Q2 		$268K Sell
4,239
-75,200
-95% -$6.45M ﹤0.01% 4659
2023
Q1 		$12M Buy
79,439
+2,702
+4% +$547K ﹤0.01% 3219
2022
Q4 		$21.9M Buy
76,737
+65,814
+603% +$12.6M ﹤0.01% 2987
2022
Q3 		$2.46M Sell
10,923
-159
-1% -$67.5K ﹤0.01% 4081
2022
Q2 		$5.36M Buy
+11,082
New +$13.1M ﹤0.01% 3788

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BlackRock's NUTX Position: Q1 2026 in Review

BlackRock increased its Nutex Health (NUTX) stake by 35% in Q1 2026, buying an estimated $12M and bringing the position to 379,355 shares worth $36.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2725.

BlackRock first reported a position in NUTX in Q2 2022 and has held it in 16 quarters since. The position peaked at $46.3M in Q4 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • BlackRock held 379,355 shares of Nutex Health worth $36.1M as of Q1 2026.
  • BlackRock bought 97,802 Nutex Health shares in Q1 2026, an estimated $12M.
  • Nutex Health made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #2725 holding.
  • BlackRock first reported a position in Nutex Health in Q2 2022 and has held it in 16 quarters since.
  • BlackRock's Nutex Health position peaked at $46.3M in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.